PharmaVoice Logo

Healthcare Leaders Hub

Sponsored content

Featured promotional

Jeplus.in
Sponsored

Jeplus.in

Purchase All Medicines.Get 10% Offer

News

Latest stories

ET Pharma

Nov 1, 2026, 5:46 AM

Court drops CBI bribery charges against ex-drug controller, 3 others

In June 2022, the CBI registered a case against Dr Eswara Reddy for manipulating the SEC review of three product approval files, However the Rouse Avenue District Court observed that the prosecution had “failed to establish even a prima facie case for the offences alleged in the charge sheet

Express Pharma

Nov 1, 2026, 5:39 AM

Express Pharma November 2026

India's Foremost Pharma & Biotech Magazine ~ PLI 2.0: Can MSMEs Catch Up? The post Express Pharma November 2026 appeared first on Express Pharma.

ET Pharma

Oct 31, 2026, 8:37 AM

AstraZeneca kicks off $1.5 billion savings drive to invest in drug pipeline

⁠On a press call, executives said some departments face cutbacks or restructuring, while others will re-skill and hire for emerging needs. Soriot said shifting ​focus from patent-expiring drugs such as Farxiga and Brilinta to oncology and rare diseases could render some R&D roles redundant.

ET Pharma

Oct 30, 2026, 11:28 PM

Sun Pharma terms recalled eye drugs production halt a ‘voluntary call’

Speaking to analysts, Kirti Ganorkar MD, Sun Pharma said, "there are 11 ophthalmology products which we have voluntarily recalled. We voluntarily initiated a temporary cessation of our manufacturing activities, and we have kept the Indian regulator informed about it.”

Pharma Tech

Oct 30, 2026, 4:38 PM

IDWeek 2026: early ensitrelvir PEP may benefit breakthrough and established Covid-19

At IDWeek 2026, Akimasa Fukushi from Shionogi presented a subpopulation analysis of the Phase III SCORPIO-PEP trial.

Pharma Tech

Oct 30, 2026, 4:28 PM

IDWeek 2026: ISL/LEN on track to become the first once-weekly oral HIV therapy

At IDWeek 2026, Samir K Gupta presented a pooled analysis of the Phase III ISLEND-1 and ISLEND-2 trials evaluating once-weekly ISL/LEN in adults with virologically suppressed HIV.

News

Latest industry coverage

Google News

Nov 1, 2026, 7:44 AM

CluePoints Positions RBQM Architecture as Foundation for Clinical Monitoring - The Clinical Trial Vanguard

CluePoints Positions RBQM Architecture as Foundation for Clinical Monitoring  The Clinical Trial Vanguard

Google News

Nov 1, 2026, 7:32 AM

Daewon Pharmaceutical enters the 400 billion won P-CAB market… Diversification of domestic competitive landscape expected - 머니투데이

Daewon Pharmaceutical enters the 400 billion won P-CAB market… Diversification of domestic competitive landscape expected  머니투데이

Google News

Nov 1, 2026, 7:30 AM

Gland Pharma Appoints Ajay Sahni as CEO of Singapore-Based International Subsidiary - Medical Dialogues

Gland Pharma Appoints Ajay Sahni as CEO of Singapore-Based International Subsidiary  Medical Dialogues

Google News

Nov 1, 2026, 7:19 AM

India 2030: Who Supplies the Next 10 Million? - BioSpectrum India

India 2030: Who Supplies the Next 10 Million?  BioSpectrum India

Google News

Nov 1, 2026, 7:18 AM

Cancer Drug Price Reset: NPPA Tightens Compliance as Supreme Court Eyes Wider Controls - BioSpectrum India

Cancer Drug Price Reset: NPPA Tightens Compliance as Supreme Court Eyes Wider Controls  BioSpectrum India

Google News

Nov 1, 2026, 7:05 AM

Anuh Pharma (NSE:ANUHPHR): Did It Publish Q2 FY27 Financial Results in Newspapers? - Kalkine India

Anuh Pharma (NSE:ANUHPHR): Did It Publish Q2 FY27 Financial Results in Newspapers?  Kalkine India

Google News

Nov 1, 2026, 6:15 AM

Biocon Ranks 13th Among World's Top 20 Biopharma Employers in Science Magazine's 2026 Survey - Medical Dialogues

Biocon Ranks 13th Among World's Top 20 Biopharma Employers in Science Magazine's 2026 Survey  Medical Dialogues

Google News

Nov 1, 2026, 5:46 AM

Court drops CBI bribery charges against ex-drug controller, 3 others - pharma.economictimes.indiatimes.com

Court drops CBI bribery charges against ex-drug controller, 3 others  pharma.economictimes.indiatimes.com

Google News

Nov 1, 2026, 5:30 AM

Indian Bank targets ₹100 crore lending under EV charging scheme in FY27: MD - Business Standard

Indian Bank targets ₹100 crore lending under EV charging scheme in FY27: MD  Business Standard

Sponsored placement

Featured promotions

Jeplus.in
Sponsored

Jeplus.in

Purchase All Medicines.Get 10% Offer